Ashkan Shoamanesh

Thrilled to share that the OCEANIC-STROKE trial (NCT05686070), led by @PHRIresearch & @BayerPharma, has successfully completed enrolment of over 12,300 participants with non-cardioembolic ischemic #stroke over a recruitment period of only 26-months! 🔗phri.ca/oceanicstroke/

It is with great sadness that I share the news of our beloved mother's unexpected passing. She was deeply loved and is sorely missed. Her obituary and details on her memorial can be found in the following link: mountpleasantgroup.permavita.com/site/JallehKer…

Does Hemorrhagic Infarction Affect Stroke Recovery? Evidence from PACIFIC-STROKE In this #BloggingStroke post, @kharsimran14 discusses #Stroke article by @Antonyneuro et al. ahajournals.org/do/10.1161/blo… @PoojaKhatriMD @VCI_EricSmith @HanneKChr @gmdemarchis @Ash_Shoamanesh

Don’t delay DOACs after stroke with AF, global study urges: thelimbus.co.uk/neurology/dont…

"My vision is that no patient would be left with a diagnosis of stroke because of an unknown cause." Dr. @nishita_singh3 aims to revolutionize stroke causes and treatment. Watch and learn about the best outcome of Dr. Nishita Singh's research and read more. #StrokeMonth

Collaboration on the optimal timing of anticoagulation after ischaemic #stroke and atrial fibrillation #Afib: systematic review and prospective individual participant data meta-analysis of RCTs (CATALYST)@LHCHFT @LivHPartners @LJMU_Health sciencedirect.com/science/articl…

#MondayTip 📊Pooled INTERACT data ✅Intensive BP lowering improves recovery in ICH ⏱️When started <3h (cutoff: 2.6h)➡️reduces haematoma growth ☝️Greatest benefit in mild–moderate ICH (ICH score) 🚨Early treatment improves outcomes👉supports CODE-ICH systems & future trial design

APOE epsilon ε4 is a significant risk factor for intracranial hemorrhage in patients with atrial fibrillation on apixaban. ja.ma/442CjwX @sheth_kevin @MrDisability

Direct comparison of apixaban with rivaroxaban for treatment of VTE shows excess bleeding with rivaroxaban in the COBRA randomized trial.

Want an insight into the CERES-TANDEM study, which investigated the use of emergent carotid stenting during thrombectomy in patients with anterior circulation tandem lesion #stroke? Then watch our recent interview with @MicheleRomoli here: 👉 ow.ly/JVbg50W8nNy #ESOC2025

News from the Swiss Stroke Registry by ⁦@mbgoeldlin: DWI-lesions in ICH are frequent, already on admission before any intervention; associationbwith CAA and SVD burden. Suitable surrogate outcome in trials?@StrokeBern⁩ ⁦@GreenJournal⁩ neurology.org/doi/10.1212/WN…

Congrats to the 6 newest members inducted into the @CdnMedHallFame, including a former CIHR Governing Council member, CIHR funding recipients and award winners, and the first woman licensed to practise medicine in Canada. cdnmedhall.ca/induction?hsid…

Congratulations to #CMHFInd2025 Dr. Deborah Cook!  #CdnMedHallFame proudly welcomes a pioneering researcher in critical care medicine. Learn more at: cdnmedhall.ca/laureates/debo… #HonouringExcellence @CMA_Docs @Financial_MD @scotiabank @machealthsci @MacDeptMed @StJoesHamilton

Time and again, 🕰️ to BP reduction is 🔑 in #ICH management thelancet.com/journals/laneu…

Renowned neurologist and epidemiologist, Dr. Mitch Elkind helped lead the American Heart Association through a global pandemic as 2020-21 president while revolutionizing the way we think about the heart-brain connection. For his transformational impact, Dr. Elkind is a recipient…

Please welcome us in congratulating our fellows for an outstanding year! Honored to welcome our newest colleagues, Dr Ian Yahnke, Dr Paul Wechsler, and Dr Lovisa Ljungberg!!! @eva_mistry @wechsler_paul @iyahnke @strokedoc79 @CTRMDMS @PeymanShirani @NatalieKreitzer 🎓🧠🎊😊🥂

Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent. Learn more in this Special Communication. ja.ma/43ZDey9

In an insightful interview, @Diana_A_Sousa of @ULisboa_ shares highlights from clinical trials presented at #ESOC2025 and comments on the potential impact of their findings on patient care. Click to watch: 👉 ow.ly/accf50W8n8m #CTSM #NeuroTwitter #Stroke @ESOstroke

Clinical trial significantly improves blood clot detection in stroke patients news.westernu.ca/2025/06/blood-… via @westernu

🩸🧠 Potential role of GLP‑1 RAs in ICH prevention!! doi.org/10.1161/STROKE…

📈Study finds herpes zoster infection to be associated with ⬆️stroke risk within 90 days post-infection 🧠Also a stronger risk factor for ICH journals.sagepub.com/doi/full/10.11…